by | Dec 11, 2022 | Uncategorized
Irene Ghobrial, MD, will receive the William Dameshek Prize at this year’s ASH Annual Meeting & Exposition.The award is presented to an early- or mid-career hematologist who made a recent outstanding contribution to the hematology field.Ghobrial, director of the...
by | Dec 10, 2022 | Uncategorized
NEW ORLEANS — Nearly three-quarters of patients who received talquetamab for relapsed or refractory multiple myeloma had an objective response to therapy, results of the phase 1/phase 2 MonumenTAL-1 trial showed.Data from the study — presented at ASH Annual Meeting...
by | Dec 9, 2022 | Uncategorized
Source: Cure Today articles Watch Dr. Francesco Maura, Dr. Marcella Kaddoura and Mary DeRome answer questions about the future of myeloma during the CURE® Educated Patient® Multiple Myeloma Summit. Read More
by | Dec 8, 2022 | Uncategorized
Source: Cure Today articles Watch Dr. Marcella Kaddoura, from Miami Sylvester Comprehensive Cancer Center, discuss targeting myeloma with small molecules with precision medicine during the CURE® Educated Patient® Multiple Myeloma Summit. Read...
by | Dec 7, 2022 | Uncategorized
Source: Cure Today articles Watch Dr. Francesco Maura, from Miami Sylvester Comprehensive Cancer Center, discuss how personalized prediction models can be used to identify the best treatments during the CURE® Educated Patient Multiple Myeloma Summit. Read...
by | Dec 6, 2022 | Uncategorized
Source: Cure Today articles Watch Valarie Traynham, of the HealthTree Foundation, discuss the long-term journey of the disease and disparities still seen during the CURE® Educated Patient® Multiple Myeloma Summit. Read More
